374 related articles for article (PubMed ID: 19220263)
21. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
22. Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Bianco FJ; Mallah KN; Korets R; Hricak H; Scardino PT; Kattan MW
Urology; 2007 Feb; 69(2):343-6. PubMed ID: 17320675
[TBL] [Abstract][Full Text] [Related]
23. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
[TBL] [Abstract][Full Text] [Related]
24. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
Choueiri TK; Dreicer R; Paciorek A; Carroll PR; Konety B
J Urol; 2008 Mar; 179(3):906-10; discussion 910. PubMed ID: 18207194
[TBL] [Abstract][Full Text] [Related]
25. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266
[TBL] [Abstract][Full Text] [Related]
26. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G; Budäus L; Isbarn H; Sun M; Perrotte P; Haese A; Chun FK; Schlomm T; Steuber T; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
Eur Urol; 2010 Apr; 57(4):562-8. PubMed ID: 20018437
[TBL] [Abstract][Full Text] [Related]
27. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
Schroeck FR; Sun L; Freedland SJ; Jayachandran J; Robertson CN; Moul JW
Prostate Cancer Prostatic Dis; 2008; 11(4):371-6. PubMed ID: 18427570
[TBL] [Abstract][Full Text] [Related]
28. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.
Mann MJ; DeCastro GJ; Desai M; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1203-7. PubMed ID: 18674807
[TBL] [Abstract][Full Text] [Related]
29. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
30. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
Chun FK; Briganti A; Jeldres C; Erbersdobler A; Schlomm T; Steuber T; Gallina A; Walz J; Perrotte P; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2007 Apr; 51(4):949-55; discussion 955. PubMed ID: 16904818
[TBL] [Abstract][Full Text] [Related]
31. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
Cooperberg MR; Freedland SJ; Pasta DJ; Elkin EP; Presti JC; Amling CL; Terris MK; Aronson WJ; Kane CJ; Carroll PR
Cancer; 2006 Nov; 107(10):2384-91. PubMed ID: 17039503
[TBL] [Abstract][Full Text] [Related]
32. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
[TBL] [Abstract][Full Text] [Related]
33. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
[TBL] [Abstract][Full Text] [Related]
34. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
Shariat SF; Karam JA; Walz J; Roehrborn CG; Montorsi F; Margulis V; Saad F; Slawin KM; Karakiewicz PI
Clin Cancer Res; 2008 Jun; 14(12):3785-91. PubMed ID: 18559597
[TBL] [Abstract][Full Text] [Related]
35. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.
Jeong IG; Lim JH; You D; Kim MH; Choi HJ; Kim JK; Cho KS; Hong JH; Ahn H; Kim CS
J Urol; 2013 Dec; 190(6):2054-60. PubMed ID: 23791890
[TBL] [Abstract][Full Text] [Related]
36. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
Graefen M; Augustin H; Karakiewicz PI; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino PT; Kattan MW; Huland H
Urologe A; 2003 May; 42(5):685-92. PubMed ID: 12750804
[TBL] [Abstract][Full Text] [Related]
37. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
[TBL] [Abstract][Full Text] [Related]
38. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
[TBL] [Abstract][Full Text] [Related]
39. Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy.
Parsons JK; Partin AW; Trock B; Bruzek DJ; Cheli C; Sokoll LJ
BJU Int; 2007 Apr; 99(4):758-61. PubMed ID: 17378839
[TBL] [Abstract][Full Text] [Related]
40. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
Vira MA; Guzzo T; Heitjan DF; Tomaszewski JE; D'Amico A; Wein AJ; Malkowicz SB
BJU Int; 2008 May; 101(10):1232-6. PubMed ID: 18419697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
